Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients.

Faraj, Alan; Le Moan, Natacha; Gorina, Eduard; Blouse, Grant E; Knudsen, Tom; Simonsson, Ulrika S H

Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients.

Faraj, Alan; Le Moan, Natacha; Gorina, Eduard; Blouse, Grant E; Knudsen, Tom; Simonsson, Ulrika S H.

Afiliação

Faraj A; Department of Pharmaceutical Biosciences, BMC, Uppsala University, Box 591, 751 24, Uppsala, Sweden.
Le Moan N; Catalyst Biosciences, South San Francisco, CA, USA.
Gorina E; Catalyst Biosciences, South San Francisco, CA, USA.
Blouse GE; Catalyst Biosciences, South San Francisco, CA, USA.
Knudsen T; Catalyst Biosciences, South San Francisco, CA, USA.
Simonsson USH; Department of Pharmaceutical Biosciences, BMC, Uppsala University, Box 591, 751 24, Uppsala, Sweden. ulrika.simonsson@farmbio.uu.se.

Adv Ther ; 40(9): 3739-3750, 2023 09.

Article em En | MEDLINE | ID: mdl-37341915

Assuntos

Hemofilia B; Humanos; Criança; Adulto; Hemofilia B/tratamento farmacológico; Fator IX/uso terapêutico; Hemorragia/tratamento farmacológico

Palavras-chave

Dalcinonacog alfa; Dose selection; Hemophilia B; MID3; Population pharmacokinetics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia B Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google